Provenance du réseau au premier degré de Audrey Legentil-Duméry
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Audrey Legentil-Duméry via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| COMPUGEN LTD. | Biotechnology | Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| TRANSGENE | Biotechnology | Director/Board Member | |
| Aventis, Inc. | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
Qualyst, Inc.
 Qualyst, Inc. Medical/Nursing ServicesHealth Services Qualyst Transporter Solutions LLC provides hepatic drug transporter products and contract research services utilizing the patented B-CLEAR technology. The company was founded by Kenneth R. Brouwer, Gary M. Pollack and Dhiren R. Thakker in 2001 and is headquartered Durham, NC. | Medical/Nursing Services | Director/Board Member | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Pharmaleads SA
 Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Director/Board Member | |
| UCB | Pharmaceuticals: Major | Director/Board Member | |
| STALLERGENES | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
EXAIL SAS
 EXAIL SAS Aerospace & DefenseElectronic Technology iXBlue SAS manufactures navigation systems using high-spec fiber-optic gyroscopes. The firm offers surface gyrocompasses, photonic components and modules, motion simulators, stabilized platforms, testing and calibration tables, optical fibers and modulators, surface and unmanned underwater vehicle navigators, and space sensors. The company was founded on September 27, 2000 and is headquartered in Saint-Germain-en-Laye, France. | Aerospace & Defense | Director/Board Member | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal Director of Finance/CFO | |
UCB Pharma SA (France)
 UCB Pharma SA (France) Pharmaceuticals: MajorHealth Technology Part of UCB SA, UCB Pharma SA (France) specializes in allergic and respiratory diseases and disorders. The company is based in Nanterre, France. | Pharmaceuticals: Major | Director/Board Member | |
| Technical University of Denmark | College/University | Doctorate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
VAXON Biotech SA
 VAXON Biotech SA Pharmaceuticals: MajorHealth Technology VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
iXLife Capital SAS
 iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Investment Managers | Chief Executive Officer | |
| University of Liege | College/University | Doctorate Degree | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| National Institute of Allergy & Infectious Diseases | General Government | Corporate Officer/Principal | |
| AB SCIENCE | Pharmaceuticals: Other | Founder | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | President | |
BioWin ASBL
 BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
| EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| Académie Royale De Médecine De Belgique | Corporate Officer/Principal | ||
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Astarix | Founder | ||
Institut de Recherches Internationales Servier
 Institut de Recherches Internationales Servier Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Institut de Recherches Internationales Servier is a French company that provides scientific research and development services. The company is based in Suresnes, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Biotechnology | Chairman | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| iXfund SAS | Director/Board Member | ||
ATANIS Biotech AG
 ATANIS Biotech AG Miscellaneous Commercial ServicesCommercial Services ATANIS Biotech AG is a company based in Oberkirch, Germany that provides a functional allergy diagnostic screening test. The German company's mission is to revolutionize the way allergies are diagnosed and improve treatment success. The company is driven by scientific excellence and provide a proprietary mast cell line that functions as an ex vivo alternative to in vivo testing. Noemi Bachmeier-Zbären, Jean-Pierre Kinet has been the CEOs since 2021. The company was founded in 2021 by Alexander Eggel, Thomas Kaufmann, Noemi Bachmeier-Zbären, Jean-Pierre Kinet. | Miscellaneous Commercial Services | Chief Executive Officer | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member Director/Board Member |
Statistiques
Internationale
| France | 20 |
| Etats-Unis | 16 |
| Belgique | 8 |
| Danemark | 3 |
| Norvège | 3 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 6 |
| Commercial Services | 6 |
| Health Services | 3 |
| Process Industries | 3 |
Opérationnelle
| Director/Board Member | 101 |
| Independent Dir/Board Member | 47 |
| Chairman | 43 |
| Corporate Officer/Principal | 37 |
| President | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Russell Greig | 31 |
| Joseph Zakrzewski | 30 |
| Jean-Pierre Kinet | 26 |
| Jean Bizzari | 24 |
| Patrick J. Langlois | 23 |
| Graham Dixon | 18 |
| Elvira Sanz Urgoiti | 16 |
| Thomas Hofstaetter | 10 |
| Shefali Agarwal | 9 |
| Jacques Mallet | 8 |
| Danièle Guyot-Caparros | 8 |
| Judith Greciet | 7 |
| Bryan Giraudo | 7 |
| Christine Garnier | 6 |
| Julien Miara | 4 |
- Bourse
- Insiders
- Audrey Legentil-Duméry
- Connexions Sociétés
